| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | GILEAD SCIENCES INC | 2,331,231 | 235,897,000 | 8.55% | ||
| 2 | CELGENE CORP | 1,713,634 | 205,225,000 | 7.44% | ||
| 3 | BIOGEN INC | 450,533 | 138,021,000 | 5.01% | ||
| 4 | VERTEX PHARMACEUT | 1,033,503 | 130,046,000 | 4.72% | ||
| 5 | ALLERGAN PLC | 409,586 | 127,996,000 | 4.64% | ||
| 6 | ALEXION PHARMACEUTIC | 636,805 | 121,471,000 | 4.40% | ||
| 7 | JOHNSON & JOHNSON | 940,988 | 96,658,000 | 3.51% | ||
| 8 | INCYTE | 880,461 | 95,486,000 | 3.46% | ||
| 9 | TEVA PHARMACEUTICAL INDS LTD | 1,334,237 | 87,579,000 | 3.18% | ||
| 10 | REGENERON PHARMACEUTICALS | 154,266 | 83,746,000 | 3.04% | ||
| 11 | ILLUMINA INC | 434,341 | 83,370,000 | 3.02% | ||
| 12 | BIOMARIN | 596,145 | 62,452,000 | 2.26% | ||
| 13 | PFIZER INC | 1,802,291 | 58,178,000 | 2.11% | ||
| 14 | AMGEN INC | 321,640 | 52,212,000 | 1.89% | ||
| 15 | UNITEDHEALTH GROUP INC | 409,100 | 48,127,000 | 1.75% | ||
| 16 | ALKERMES PLC SHS | 510,444 | 40,519,000 | 1.47% | ||
| 17 | MERCK & CO INC | 681,097 | 35,976,000 | 1.30% | ||
| 18 | SHIRE PLC | 171,813 | 35,222,000 | 1.28% | ||
| 19 | MEDIVATION INC | 667,300 | 32,257,000 | 1.17% | ||
| 20 | AGILENT TECHNOLOGIES INC | 728,650 | 30,465,000 | 1.10% | ||
| 21 | HCA HOLDINGS INC | 448,488 | 30,331,000 | 1.10% | ||
| 22 | MYLAN N V | 531,252 | 28,725,000 | 1.04% | ||
| 23 | HUMANA | 129,300 | 23,081,000 | 0.84% | ||
| 24 | ACADIA PHARMACEUTICALS INC COM | 637,500 | 22,727,000 | 0.82% | ||
| 25 | MOLINA HEALTHCARE INC | 347,901 | 20,919,000 | 0.76% | ||
| 26 | VENTAS INC | 369,266 | 20,838,000 | 0.76% | ||
| 27 | PHYSICIANS RLTY TR | 1,230,772 | 20,751,000 | 0.75% | ||
| 28 | PUMA BIOTECHNOLOGY | 260,200 | 20,400,000 | 0.74% | ||
| 29 | ISHARES TR | 57,670 | 19,511,000 | 0.71% | ||
| 30 | MEDICAL PPTYS TRUST INC | 1,564,060 | 18,002,000 | 0.65% | ||
| 31 | NEUROCRINE BIOSCIE COM USD0.001 | 311,460 | 17,619,000 | 0.64% | ||
| 32 | ENDO INTL | 286,348 | 17,530,000 | 0.64% | ||
| 33 | NOVO-NORDISK A S | 294,600 | 17,110,000 | 0.62% | ||
| 34 | MCKESSON CORP | 82,862 | 16,343,000 | 0.59% | ||
| 35 | HORIZON PHARMA PLC | 749,900 | 16,250,000 | 0.59% | ||
| 36 | ST JUDE | 255,810 | 15,801,000 | 0.57% | ||
| 37 | MEDICINES CO | 401,970 | 15,010,000 | 0.54% | ||
| 38 | IMPAX LABORATORIES INC | 344,683 | 14,739,000 | 0.53% | ||
| 39 | UNITED THERAPEUTICS | 93,100 | 14,580,000 | 0.53% | ||
| 40 | PARATEK PHARMACEUTICALS INC | 762,581 | 14,466,000 | 0.52% | ||
| 41 | OMEGA HEALTHCARE INVS INC | 413,116 | 14,451,000 | 0.52% | ||
| 42 | BRISTOL MYERS SQUIBB CO | 202,600 | 13,937,000 | 0.51% | ||
| 43 | CORSICANTO LTD | 14,700,000 | 13,304,000 | 0.48% | PRN | |
| 44 | SANOFI | 305,000 | 13,008,000 | 0.47% | ||
| 45 | ALNYLAM PHARMACEUTICALS INC | 137,495 | 12,944,000 | 0.47% | ||
| 46 | BAXALTA INC | 319,600 | 12,474,000 | 0.45% | ||
| 47 | Anacor Pharmaceuticals Inc | 110,038 | 12,431,000 | 0.45% | ||
| 48 | THERMO FISHER SCIENTIFIC INC | 86,395 | 12,255,000 | 0.44% | ||
| 49 | BAXTER INTL INC | 319,600 | 12,193,000 | 0.44% | ||
| 50 | CEPHEID | 333,590 | 12,186,000 | 0.44% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-16-094941, filed 2016.02.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
